Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
Recruiting · NCT05526989 · Registry updated 2025-12-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, penile carcinoma, penile disorder, penile neoplasm | Recruiting | Phase 2 | 2025-12-04 | NCT05526989 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GlaxoSmithKline | 294 |
| H. Lee Moffitt Cancer Center and Research Institute | 162 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |
| Moffitt Cancer Center | Tampa | United States | 523 |